|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, and the Health Research Institute, Chulalongkorn University, Bangkok, Thailand.
Address reprint requests to: Nimit Taechakraichana, MD, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok 10330, Thailand E-mail: fmedntk{at}md2.md.chula.ac.th
Objective: To identify the effects of oral contraceptive (OC) and hormone replacement therapy (HRT) on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Methods: Eighty healthy postmenopausal women were randomly assigned to a cyclic regimen of OC containing 30 µg of ethinyl estradiol and 150 µg of desogestrel or HRT containing 0.625 mg of conjugated equine estrogens 21 days per cycle and 5 mg of medrogestone 10 days per cycle for 12 months. Bone mineral density of lumbar spine and hip, biochemical markers of bone turnover, lipid-lipoprotein profiles, coagulation profiles, fasting plasma glucose, and blood pressure were evaluated.
Results: Both regimens caused significant increase in bone mineral density of lumbar spine, trochanter, intertrochanteric region, total hip, and Ward triangle. Only OC therapy was associated with a significant increase in femoral neck bone mineral density (mean score ± standard error 2.5% ± 0.7%, P < .01). Biochemical markers of bone turnover, total cholesterol, and low-density lipoprotein cholesterol decreased significantly in both groups. Posttreatment levels of those bone markers and lipid-lipoprotein were significantly lower after OC therapy than HRT. Fasting plasma glucose and systolic blood pressure decreased significantly in both groups; however, only the OC group showed a significant decrease in diastolic blood pressure.
Conclusion: Both OC and HRT increased bone mineral density of lumbar spine and hip, but OC suppressed bone turnover more than HRT. Both methods favorably affected lipid-lipoprotein metabolism, fasting plasma glucose, and blood pressure during the 12 months of treatment.
This article has been cited by other articles:
![]() |
F. A. Wentorf, K. Sudoh, C. Moses, E. A. Arendt, and C. S. Carlson The Effects of Estrogen on Material and Mechanical Properties of the Intra- and Extra-articular Knee Structures Am. J. Sports Med., December 1, 2006; 34(12): 1948 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
The ESHRE Capri Workshop Group Noncontraceptive health benefits of combined oral contraception Hum. Reprod. Update, September 1, 2005; 11(5): 513 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Nurs., October 1, 2000; 3(4): 106 - 112. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |